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High Efficiency Gene Transfer into
Atherosclerotic Lesions in Hypercholesterolemic
Rabbit Carotid Arteries
Platelet - Stimulated Proliferation of Coronary
Smooth Muscle Cells
I. II. III. IV V
PDGF-BB PDGF-BB PDGF-BB PDGF-BB PLA
+bFGF +bFGF+EGF +bFGF+EGF+ILGF-1
H-SMC 17 ± 6 22 ± 12 22 ± 8 43 ± 13# 73 ± 21*
P-SMC 16 ± 9 23 ± 17 21 ± 11 41 ± 14# 69 ± 16*
1914-711
# p < 0.05 vs. I. II and III. *p < 0.05 vs I, II, III and IV
Conclusion: Platelet-induced SMC-PROL in vitro significantly exceeds the
stimulatory effect of individual and combined growth factors suggested to
cause SMC proliferation after coronary angioplasty in vivo. Further studies
need to clarify this effect. which might have important implications for anti-
coagulation during coronary angioplasty.
Human coronary smooth muscle cells (SMC)from atherectomized restenotic
lesions and porcine SMC from lesions 4 weeks after coronary angioplasty
(explant technique) were cultivated to passage 3 to 7. Human platelets (H-
PLA) and porcine platelets (P-PLA) were isolated from citrate-anticoagulated
blood (60 ml, platelet recovery 20 ± 2% of whole blood concentration). SMC
proliferation (PROL) was assessed using 3H-Thymidin incorporation. PROL
following 24 hrs stimulation with 10% fetal calf serum (FCS) averaged 3200
cpm/1 000 SMC and was used as 100% reference for the analysis of platelet-
induced PROL. Both H-PLA and P-PLA stimulated PROL of SMC in a concen-
tration dependent manner with a maximum of 73 ± 21 % (H-PLA, 5 x 104/ILI)
and 69 ± 16% (P-PLA, 22.5 x 104/ILI) of FCS values (mean ± SD). Similar re-
sults were obtained with PLA lysed by sonication. Parallel experiments using
the growth factors PDGF-BB, bFGF, EGF and ILGF-1 alone or in combination
at their maximal effective concentrations showed significantly less stimula-
tion (p < 0.05, AN OVA). PDGF-BB at 50 ng/ml was the most potent stimulat-
ing individual growth factor (17 ± 6% (H-PLA) and 16 ± 9% (P-PLA) of FCS
values.
Results: (PROL-% FCS-values, mean ± SD)
Christina Unterberg, Thomas Meyer, Albert Smolenski, Arnd B. Buchwald. Dept. of
Cardiology, University Clinic, Gottingen, Germany
Heiko E. von der Leyen, Michael J. Mann, Gary H. Gibbons, Victor J. Dzau. Stanford
University, Stanford, CA
The feasibility of using in vivo gene transfer to induce the regression of
atherosclerotic lesions remains to be defined. Accordingly, we have devel-
oped a rabbit model of atherosclerosis that consists of (i) a high cholesterol
diet beginning 2 weeks prior to vascular injury (cholesterol levels: 1,000-
2,000 mg/dl), (iii balloon-injury (2 F Fogarty catheter) to the common carotid
artery via the internal carotid artery, and (iii) gene transfer into the vessel wall
2 weeks after balloon injury by a second interventional procedure. Balloon
injury resulted in consistent formation of neointimal lesions (intima/media
ratio: 1.0-1.4; n = 3) throughout the injured vessel segment.
Immunohistochemical staining against macrophages (RAM-ll) showed
a broad distribution of macrophages throughout the neointima and media.
Transfection efficiency into the injured vessel wall was determined using a fJ-
galactosidase (fJ-gal) reporter gene (SV40-promoter) and the highly efficient
Sendai virus (HVJ)-mediated gene delivery method in which plasmid vec-
tors are complexed with Iiposomes, nuclear protein and UV-inactivated viral
protein coat. Histochemical analysis after transfection revealed strong fJ-gal
activity (@ 30-50% of cells transfected) within the neointima and media,
whereas controls (control vector transfected and/or balloon injured vessel)
showed no staining. Double staining with the macrophage antibody showed
that not only smooth muscle cells and fibroblasts, but also macrophages
were genetically modified. We conclude that the rabbit atherosclerotic
carotid artery is a suitable model for studying gene transfer as a therapeutic
approach to vascular disease.
Expression of as!J1 Integrin in Human Vascular
Smooth Muscle Cells: A Potential Mediator for
Vascular Remodeling
An Orally Active Synthetic lib/ilia Receptor
Antagonist Inhibits Ex-vivo Platelet·Thrombus
Formation
J. Geoffrey Pickering, Lawrence H. Chow, Carol M. Ford, Shashi Uniyal, Bosco
M. Chan. Robarts Research Institute and University Hospital, London, Canada
Integrins are heterodimeric (a fJ) cell surface proteins that promote attach-
ment to the extracellular matrix. Their role in vascular lesion formation is un-
known. The a5fJ1 integrin can, however, interact with fibronectin which has
been implicated in lesion formation following vascular injury and can pro-
mote vascular smooth muscle cell (SMC) activation. Therefore, we tested
the hypothesis that SMC activation is functionally linked to a5fJ1 integrin ex-
pression.
To determine which integrins are expressed on human SMCs, cells were
cultivated from internal mammary artery (IMA) and surface-labeled with 1251.
Lysates were immunoprecipitated using a panel of subtype-specific anti-
integrin antibodies. This identified 5 fJ1 integrins: a1 fJl and a2fJl integrins,
which were expressed at relatively low levels, and a3fJl ,a5fJ1 and a6fJ1 inte-
grins which were abundantly expressed. The cellular location of a5fJ1 integrin
was studied by confocal microscopy of SMCs seeded on to fibronectin. This
revealed discrete linear accummulations of the a5 integrin subunit on the
bottom surface of the cell, consistent with focal adhesion plaques. The role
of the "5fJ1 integrin in mediating an interaction with fibronectin was evalu-
ated by adhesion assay. SMCs adhered fully to afibronectin-coated substrate
within 30 min. In contrast, when SMCs were incubated with an anti-<l5 inte-
grin antibody, adherence was reduced by 65% (p < 0.05). Finally, to assess
integrin expression in quiescent SMCs, sections of human IMA were studied
by immunofluorescence microscopy. In contrast to the abundant expression
in activated SMCs proliferating in vitro, quiescent SMCs in the arterial media
stained weakly for a5 integrin.
Conclusion: The a5fJl integrin is selectively expressed in human SMCs
when activated and mediates a functional interaction with fibronectin. This
receptor therefore may be a critical modulator of SMC behavior following
vessel injury.
in oral or IV form, it blocks the final step in platelet activation by blocking
the platelet Gpllbilla, thus protecting against platelet activation by elevated E
and shear stress produced by very severe stenosis. It is also likely to be more
effective than ASA for reducing the platelet contribution to atherosclerosis
preventing coronary thrombosis and fatal or non fatal myocardial infarction
and early and late PMT after angioplasty or atherectomy procedures.
Juan J. Badimon, Beat Meyer, Larry Feigen 1, James Chesebro, Valentin Fuster,
Lina Badimon. Cardiovascular Institute, Mount Sinai Hospital, New York; 1SEARLE,
Skokie, IL; Cardiovascular Research Center CID rCSIC)-Hospital San Pablo, Barcelona,
Spain
Coronary artery disease and its progression is clearly linked to thrombosis.
Thrombosis has been successfully inhibited by using several drugs when
given Lv. The use of i.v. drugs is useful to prevent thrombosis in acute sit-
uations; but long-term inhibition of platelet activity will require orally ac-
tive drugs. The available oral agents (ASA, Ticlopidinel have a limited an-
tiplatelet effect. Platelet-fibrinogen binding inhibition by oral administration
of SC-54684A (synthetic mimetic of the RGO-sequence) has been tested as
a strategy to prevent thrombosis. This compound is currently undergoing
clinical trials. Platelet deposition (PO) has been evaluated by 111 In-platelets
in an "ex vivo" canine perfusion model (Badimon's chamberl. Effects of SC-
54684A (3 mglkg; doses that totally block in vitro platelet aggregation) on
PO have been tested on mildly (MI) and severely injured (SI) aortic wall, at
flow conditions modeling shear rates (SR) typical of medium size patent (212
s-l) and stenotic (1690 s-1) arteries after 5 min perfusions. PD results are
expressed as (platelets x 106/cm2) (mean ± SE)
1914-691
*p < 0.05
Our results demonstrate that oral administration of a synthetic peptide an-
tagonist of the lib/lila platelet receptor significantly reduces platelet throm-
bus formation on stenosed severely injured lesions where there is a higher
risk of thrombotic occlusions. This novel oral approach may have important
clinical implications.
1914-731
Substrate
Flow conditions
Control
SC-54684A
Mild injury
212/s
3.5 ± 0.7
6.2 ± 1.2
1690ls
9.8 ± 32
9.6 ± 1.7
Severe injury
212/s
16.0 ± 3.4
17.2 ± 1.3
1690/s
49.3 ± 4.2
25.8 ± 1.3*
Effects of Hypothyroidism on Neointima
Formation Following Vascular Injury in the Rat
Carotid Artery
G. Mark Jenkins, Cynthia Nater, Claudio Bilato, Jeffrey Froehlich, Linda Cheng.
Laboratory of Cardiovascular Science, Gerontology Research Center. NlA. NIH,
Baltimore, MD
Neointima formation following vascular injury is reduced in hypophysec-
tomized rats indicating that pituitary-derived hormonal factors likely regulate
vascular smooth muscle cell (VSMC) migration and proliferation in vivo. In
order to specifically investigate the role of thyroid hormone in intimal thick-
ening following balloon injury, we made rats hypothyroid by dietary manipu-
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ATP-sensitive Potassium Channels Contribute to
Reactive Hyperemia in Humans
Peter F. Banitt. Paul Smits, Stephen B. Williams, Peter Ganz, Mark A. Creager.
Brigham and Women's Hospital, Boston, MA
Plasma endothelin-1, ET-1, and the precursor, big ET-1, are demonstrable
in healthy man and increase during e.g. myocardial infarction (Miyauchi et
al 1989). To study the vascular effects of big ET-1 infusion, and its possi-
ble conversion of ET-1, healthy subjects received big ET-l in doses of 4-8
pmol.kg-1.min-1 intravenously for 20 minutes. Blood samples were taken
from systemic arterial and pulmonary arterial as well as jugular, deep fore-
arm, hepatic and renal vein catheters for determination of cardiac output,
CO, splanchnic (ESBF) and renal (ERBF) blood flows (indicators: cardiogreen
and PAH) forearm blood flow (FBF, pletysmographyl. and big ET-1 and ET-1
like immuno-reactivity, (ET-1-LiI. Big ET-l infusion caused a decrease in heart
rate, HR, from 57 ± 4 to 45 ± 3 beats.min-1 (p < 0.001) and increase of
mean arterial pressure, MAP. from 86 ± 1.3 to 106 ± 3.2 mmHg (p < 0.001).
CO fell by 22 ± 5% (p < 0.01). Pulmonary, splanchnic and renal oxygen up-
takes were unchanged indicating that big ET-1 does not influence oxygen
consumption. The arterial-jugular venous oxygen difference was unchanged
indicating unchanged cerebral blood flow. FBF was unchanged. ERBF and
ESBF fell by approximately 40% (both p < 0.001). Only splanchnic and re-
nal tissues extract big ET-1 with fractional extractions of 23 ± 4 and 45 ±
4%. Intravenous infusion of big ET-1 increased arterial ET-1-Li from 4 to 8
pmol.I-1 (p < 0.001) and renal release of ET-1-Li from 1.50 ± 0.18 to 8.68 ±
0.64 pmol.min-1 (p < 0.001). Conclusion: Big ET-1 infusion causes falls in
HR and CO, increase in MAP and decreases in splanchnic and renal blood
flows. Uptakes of big ET-l were only noted in the renal and splanchnic re-
gions with two-fold higher values in the kidneys, p < 0.005. Only the kidney
showed increased release of ET-1-Li suggesting a unique renal capacity to
synthesize and release big ET-1 . Compared to ET-l infusion (Weitzberg et al
1991) big ET-l infusion causes, despite lower arterial plasma ET-1-Li levels,
more marked haemodynamic effects as reflected in drops in HR and CO and
more marked increase in MAP with more pronounced and long-lasting renal
vasoconstriction. In addition big-ET-1 had no effect on cerebral or skeletal
muscle blood flows while ET-l caused dilatations in these regions.
Activation of ATP-sensitive potassium channels (KATP) of vascular smooth
muscle causes hyperpolarization of the cell membrane and vasodilation. The
purposes of this study were 1) to determine whether KATP contribute to re-
active hyperemia following ischemia in humans, and 2) whether adenosine,
a metabolite present in ischemic muscle, activates KATP. Accordingly, we
studied the effect of tolbutamide (1 mM), a KATP inhibitor, on reactive hyper-
emic forearm blood flow in 12 normal subjects. Forearm blood flow (FBF)
was measured by venous occlusion plethysmography. Forearm ischemia
was produced by inflating a blood pressure cuff to suprasystolic pressures
for 5 minutes. Following cuff release FBF was measured during the reactive
hyperemic phase for 5 minutes. After a re-equilibration period the above pro-
tocol was repeated during intra-brachial artery infusion of either tolbutamide
1 mM (n ~ 6) or vehicle (n = 6). Blood flow was plotted vs. time and the area
under the curve was calculated after subtracting baseline flow. Tolbutamide
did not significantly alter basal FBF (2.5 ± 0.6 to 2.3 ± 1.0 ml/1 00 ml/minl, or
peak reactive hyperemic FBF (21.9 ± 9.2 to 22.6 ± 7.2 mill 00 ml!min) (each
p = ns). However, tolbutamide significantly attenuated total hyperemic flow
repayment; (156 ± 44 vs. 114 ± 32 mill 00 ml, p = 0.02). Vehicle did not
impair basal flow, peak reactive hyperemic flow or repayment. Tolbutamide
1 mM did not attenuate adenosine-induced(15-500 mM) increases in FBF (n
= 6). These data indicate that KATP contribute to vasodilation during reactive
hyperemia in humans. Activation of KATP is not mediated by adenosine.
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Big ET-1-lnfusion in Man Causes Only Renal
ET·1-Release but Potent and Long-lasting
Systemic, Pulmonary, Renal and Splanchnic
Vasoconstriction
Gunvor Ahlborg, Astrid Ottosson-Seeberger, Anette Hemsem, Jan M. Lundberg.
Institu~'on of Clinical Physiology, Huddinge Hospital and Department of Pharmacology,
Karolinska Institute, StOCkholm, Sweden
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The Role of Estradiol 17P on Free Radical
Induced Vascular Myointimal Hyperplasia
Estradiol17P Protects Against
Homocysteine-induced Vascular Injury in Rat
Thoracic Aorta
Michel Y. Farhat, Brenda Dingaan, Michael E. Fader, Peter W. Ramwell.
Georgetown University. WaShington, DC
Hyperhomocysteinemia produces atherosclerotic lesions with characteristic
endothelial desquamation and intimal smooth muscle cell IVSMCI prolifer-
ation. In vitro, homocysteine is cytotoxic to endothelial cells and recent ob-
servations suggest that it may directly stimulate VSMC proliferation. Estro-
gen, on the other hand, inhibits VSMC proliferation both in vivo and in vitro.
We evaluated the effect of estradiol 17f3 (E2f3) on homocysteine-induced
VSMC proliferation in arterial segments from the rat thoracic aorta. Seg-
ments were placed overnight in Dulbecco's Minimum Essential Medium,
supplemented with gentamycin (25 Itg/mll. glutamine (2 mMI and 0.4% fa-
tal bovine serum, before incubation for 30 hours with DL-homocysteine thi-
olactone (0.1-5.0 mM). Radiolabelled thymidine uptake was assessed in in-
tact and deendothelialized arterial segments, in presence of E2f3 (30 nM) or
vehicle (1 % ethanol). In deendothelialized segments homocysteine elicited
a concentration-dependent increase in 3H-thymidine uptake, expressed as
cpmlmg protein. Thymidine uptake increased from a basal value of 8694 ±
1465 to 36338 ± 2025, at 5 mM homocysteine concentration (p < 0.011.
Intact arterial segments showed a significantly attenuated response to ho-
mocysteine stimulation. On the other hand, incubation of deendothelialized
segments with E2f3 (30 nM) caused a significant inhibition of homocysteine-
stimulated response, without affecting basal 3H-thymidine incorporation.
These results provide evidence for a direct stimulatory effect of homocys-
teine on VSMC proliferation in rat aortic segments. Further, our data show
estradiol 17f3 protects against homocysteine-induced vascular injury, possi-
bly via a direct effect on VSMC.
lation or surgical removal of the thyroid gland. Following 2 months on a thy-
roid suppressive diet. the extent of neointimal regrowth was compared 14
days after balloon injury in hypothyroid rats (Group 1, n = 8, thyroid stimulat-
ing hormone ITSH) = 9.6 micro IU/ml) and animals maintained on a normal
diet (Group 2, n ~ 8). Neointima formation was significantly attenuated in
Group 1: intima/medial ratios were 0.904 ± 0.118 mm2 and 1.361 ± 0.061
mm2 in Groups 1 and 2 respectively, (p < 0.02). Additional experiments in
rats following thyroidectomy (n = 3) revealed a similar significant decrease
in neointima formation following balloon injury. This inhibitory effect of hy-
pothyroidism was maintained in animals who were also made hypercholes-
terolemic (Group 3, n = 8, TSH = 10.2 micro IU/ml, total cholesterol = 752
mg/dl, low-density lipoprotein = 674 mg/dl): intima/medial ratios were 1.361
± 0.061 mm2 and 0.822 ± 0.078 mm2, in Groups 2 and 3 respectively, p <
0.02. Prolonged (60 days) cholesterol feeding alone (Group 4, n = 8) as sus-
pected, did not result in elevated cholesterol levels, but also did not result
in significant differences in intimal thickness when compared to animals in
Group 2. These results suggest that thyroid hormone may be an important
co-mitogen for the proliferative response of the rat carotid artery to balloon
injury and may help partially explain the growth inhibitory effect of hypophy-
sectomy.
Sam Cathapermal, Mann Y. Leong-Son, Peter W. Ramwell. Georgetown University.
Washington, DC
Oxygen free radicals may be involved in vascular hyperplasia by promot-
ing smooth muscle cell proliferation, a response potentiated by endothelial
damage. Estradiol17f3 protects against vascular injury in experimental arte-
riosclerosis and inhibits proliferation of primary cultures of vascular smooth
muscle cells. We studied the in vitro effect of estradiol 17f3 on vascular
smooth muscle cell hyperplasia induced by the superoxide anions (OZ"). In-
tact and denuded rat aortic segments were incubated overnight at 37' C in
2 ml Eagle's minimal essential medium supplemented with gentamycin and
glutamine, without phenol red. The segments were challenged with either
vehicle alone or the Oz" generating system (Xanthine and xanthine oxidase)
for 4 hrs. We found that 0-" significantly enhanced 3H-thymidine incorpo-
ration, an effect potentiated by the absence of the endothelium (Intact ves-
sel 8.3 x 105 ± 0.1 x 105 vs denuded vessel 2.5 x 106 ± 1.3 x 105 P <
0.01). This effect was inhibited by superoxide dismutase. Estradiol 17f3 (30
nM) significantly inhibited free radical induced 3H-thymidine uptake in both
intact and denuded vessels. We conclude that an intact endothelium may
protect against free radical induced smooth muscle cell proliferation. Estra-
diol17f3 may also protect against free radical induced vascular proliferation
by a mechanism independent of the endothelium.
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